Polyrizon Ltd.
PLRZ- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001893645
No open-market purchases or sales by Polyrizon Ltd. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $2.77M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Polyrizon Ltd. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 4 | 4 | 0 |
| Shares | 35.9K | 220.8K | +185.0K (+515.6%) |
| Value | $413.6K | $2.77M | +$2.35M (+569.0%) |
New holders (4)
Institutions that held Polyrizon Ltd. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MMCAP International Inc. SPC | 199,470 | $2.50M | 0.21% |
| HRT Financial LP | 21,363 | $269.0K | 0.00% |
| Caitong International Asset Management Co., Ltd | 11 | $138 | 0.00% |
| Morgan Stanley | 3 | $38 | 0.00% |
Sold out (4)
Institutions that held Polyrizon Ltd. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| FNY Investment Advisers, LLC | 24,575 | $283.0K |
| Citadel Advisors LLC | 10,149 | $117.1K |
| Legacy Wealth Managment, LLC | 1,150 | $13.4K |
| Citigroup Inc | 1 | $12 |